DAOs & Pharma (Decentralised Autonomous Organisations)

Blockchain in Pharma Network
Blockchain in Pharma Network
Public group

Steinentorberg 18

Steinentorberg 18 · Basel

How to find us

The building next to Markthalle (Steinentorberg 18), Ring the doorbell for Linum Labs, Elevator to floor 12

Location image of event venue

Details

WTF is a DAO? How does it work? Why should we consider its applications in pharma?

For this month's Blockchain in Pharma meetup, we've chosen to focus our attention on Decentralised Autonomous Organisations (DAOs).

Here, we will dig deep into this concept with presentations from experts that have already begun building DAOs and have analyzed the intricacies of how they operate.

As with every month, we put a strong focus on harnessing full audience participation. We will then open up the floor for another roundtable debate and discussion on how you imagine DAOs to be implemented within the pharma space or if you believe it's just too Sci-fi to work.

Schedule
18h00: Arrival and networking
18h15: Opening address & welcome
18h20: WTF is a DAO: An introduction to Decentralised Autonomous Organisations - Yannick Zehnder (https://www.linkedin.com/in/yannickzehnder/)
18h40: A deep dive into DAOs & Pharma - Paul Kohlhaas
(https://www.linkedin.com/in/kohlhaas/)
18h50: Open floor discussion - How could DAOs be implemented in Pharma?
20h00: Wrap up and networking

About the Speakers:
Francis Yannick Zehnder - Founder of Zehnder Advisory

Yannick Zehnder is a marketing and sales adept with a long-standing interest for bleeding edge and emerging technologies. He works as an independent advisor on a series of startup and growth financing projects including ICOs and Security Token Offerings.
Moreover, he is a writer, blogger, speaker, teacher, a man of many hats.

Paul Kohlhaas - Founder of Molecule

Paul Kohlhaas, Founder of Molecule, is a blockchain entrepreneur with a passion for open source utility networks. After graduating in economics and politics, he co-founded Linum Labs, a blockchain architecture studio and worked as Business Development Director at ConsenSys, uPort, pioneering real-world implementations in digital identity. A profound passion for chemical and pharmaceutical economics led him to found the Molecule Protocol, a network for the decentralised R&D of molecular compounds

RSVP is essential